Mesalamine is a first-line medication used to treat and prevent mild to moderately active inflammatory bowel disease, including ulcerative colitis and Crohn’s disease. It is an anti-inflammatory medication which works by direct contact with the intestines.
Mesalamine is also known as mesalazine or 5-aminosalicylic acid (5-ASA).
Mesalamine is available as a variety of formulations administered orally or rectally (suppositories and enemas). Available forms of mesalamine differ in their route of administration (oral or rectal), strength and how often they are administered.
According to studies performed to date, the available oral formulations have similar rates of efficacy when used in the treatment of ulcerative colitis. No significant differences were reported between once daily and multiple daily mesalamine regimens.
US brand Delzicol 400 mg capsule (formerly Asacol 400 mg tablet) by Allergan – dosed orally 3 times daily
Global Alternatives: brand Asacol MR 400 mg tablet (UK) by Allegan
Brand Asacol 400 mg tablet (Canada) by Allergan
Generic Octasa 400 mg tablet (UK) by Tillotts Pharma UK
Generic Teva-5-ASA 400 mg tablet (Canada) by Teva
US brand Asacol HD 800 mg tablet – dosed orally 3 times daily
Global Alternatives: brand Asacol MR 800 mg tablets (UK) by Allergan
Brand Asacol HD 800 mg tablets (Canada) by Allergan
Generic Octasa 800 mg tablet (UK) by Tillotts Pharma UK
US brand Lialda 1.2 g tablet by Shire US Inc. – dosed orally once daily with food
Global Alternatives: brand Mezavant XL 1.2 g (UK) by Shire Pharma
Brand Mezavant 1.2 g (Canada) by Shire Pharma
US brand Pentasa 250 mg and 500 mg capsule – dosed orally 4 times daily
Global Alternatives: brand Pentasa 500 mg and 1000 mg tablet (UK) by Ferring
Brand Pentasa 500 mg and 1000 mg tablet (Canada) by Ferring
Global Alternatives not available
US brand Canasa 1000 mg suppository by Allergan (registered trademark of Aptalis Pharma)– dosed rectally at bedtime, retained for 1-3 hours or more if possible to achieve maximum benefit
Global Alternatives: brand Salofalk 500 mg and 1000 mg suppositories (Canada) by Aptalis Pharma
US brand Rowasa 4 g per 60 mL enema by Meda Pharmaceuticals – dosed rectally once daily at bedtime, retained for 8 hours
Global Alternatives: brand Salofalk enema 4 g per 60 mL (Canada) by Aptalis Pharma